Effect of Probiotic supplementation on Gut Microbiota & Telomere length in type 2 diabetes population

Determining the short term effect of Probiotic supplementation on Gut Microbiota and Telomere length in type 2 diabetes population - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/055647

Enrollment

124

Registered

2023-07-25

Start date

Unknown

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

Intervention1: Probiotic - Diabetic Population: Name of the Drug - Tata 1mg Probiotics Dose - 2 capsules Per day - Morning and Night (Before Food) Route - Oral Duration - 6 Months Control Intervention

Eligibility

Inclusion criteria

Inclusion criteria: Type 2 diabetes Individuals

Exclusion criteria

Exclusion criteria: Type 1 diabetes individual Acute diarrhea syndrome Irritable bowel syndrome Recent Gastrointestinal surgery Antibiotics - last 2 weeks Gestational diabetes Pregnancy Age group 70

Design outcomes

Primary

Measure	Time frame
Probiotic Supplementation alternate the Gut Microbiota, increase the length of Telomere & maintains the Blood Glucose LevelTimepoint: 0 to 8 Months	—

Secondary

Measure	Time frame
Probiotic Supplementation maintains the Metabolic Profile & decrease the HsCRP levelTimepoint: 0 to 8 months	—

Countries

India

Contacts

Public ContactDr J S Kumar

SRM Institute of Science and Technology

kumarj1@srmist.edu.in9840047678

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026